← 홈

CGT

1,235개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicJiangsu Topcel-KH Pharmaceutica…Phase 2

CD19 CAR T Arm (CD19 CAR T Arm)

Scleroderma, Systemic · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 16.7%임상시험 56상태 RECRUITING
CGTBiologicAllife Medical Science and Tech…Phase 3

Cytokine-induced killer cells (Cytokine-induced killer cells)

Cholangiocarcinoma · Cholangiocarcinoma

#Cholangiocarcinoma#CGT#Phase3#인기#세포유전치료+4
효능 30%임상시험 56상태 RECRUITING
CGTBiologicBristol-Myers SquibbPreclinical

Daclatasvir-Sofosbuvir (Daclatasvir-Sofosbuvir)

Chronic Hepatitis C (Disorder) · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Preclinical#인기#세포유전치료+4
효능 ORR 97%임상시험 56상태 ACTIVE
CGTBiologicDNAtrix, Inc.Phase 1

Interferon-gamma (Interferon-gamma)

Glioblastoma or Gliosarcoma · Glioblastoma or Gliosarcoma

#GlioblastomaorGliosarcoma#CGT#Phase1#인기#세포유전치료+4
임상시험 55상태 ACTIVE
CGTBiologicCarbiogene Therapeutics Co. Ltd.Phase 1

anti-BCMA CAR-T (anti-BCMA CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#인기#세포유전치료+5
효능 ORR 97.1%임상시험 55상태 ACTIVE
CGTBiologicYake Biotechnology Ltd.Phase 1

CD19/CD22 CAR T-Cells (CD19/CD22 CAR T-Cells)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
임상시험 54상태 RECRUITING
CGTBiologicShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#인기#세포유전치료+4
임상시험 54상태 ACTIVE
CGTBiologicNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 ACTIVE
CGTBiologicKitevedotin plus bendamustine a…Approved

axicabtagene ciloleucel (Yescarta, axi-cel)

Large B-cell Lymphoma; Lymphoma, B-Cell · FRα

#FR#CGT#Approved#인기#세포유전치료+5
효능 ORR 92%임상시험 53상태 RECRUITING
CGTBiologicHebei Senlang Biotechnology Inc…Preclinical

CD19+CD22 CAR-T (CD19+CD22 CAR-T)

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Preclinical#인기#세포유전치료+5
임상시험 53상태 ACTIVE
CGTBiologicCRISPR Therapeutics AGPhase 2

CD19-directed CAR-T cells (CD19-directed CAR-T cells)

B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 25%임상시험 53상태 ACTIVE
CGTBiologicMatthew FrankPhase 1

CD22 CAR (CD22 CAR)

B-ALL; B-cell Non Hodgkin Lymphoma · CD22

#CD22#CGT#Phase1#인기#세포유전치료+5
임상시험 53상태 ACTIVE
CGTBiologicHebei Senlang Biotechnology Inc…Phase 1

CD22 CAR-T (CD22 CAR-T)

Childhood Acute Lymphoblastic Leukemia · CD22

#CD22#CGT#Phase1#인기#세포유전치료+5
임상시험 53상태 ACTIVE
CGTBiologicGlaxoSmithKlinePhase 2

Eltrombopag (Eltrombopag)

Immune Thrombocytopenic Purpura · Chronic Granulomatous Disease (CGD)

#ChronicGranulomatousDiseaseCGD#CGT#Phase2#인기#세포유전치료+5
효능 ORR 10%임상시험 53상태 ACTIVE
CGTBiologicProvidence Health & ServicesPhase 1

TCR-transduced T cells (TCR-transduced T cells)

Malignant Epithelial Neoplasms · Malignant Epithelial Neoplasms

#MalignantEpithelialNeoplasms#CGT#Phase1#인기#세포유전치료+4
효능 ORR 0%임상시험 51상태 RECRUITING
CGTBiologicAllife Medical Science and Tech…sPhase 1

CRISPR/Cas9 (CRISPR/Cas9)

Human Papillomavirus-Related Malignant Neoplasm · Human Papillomavirus-Related Malignant N

#HumanPapillomavirus-RelatedMalig#CGT#Phase1#인기#세포유전치료+4
효능 ORR 25%임상시험 50상태 ACTIVE
CGTBiologicShenzhen Geno-Immune Medical In…sPreclinical

Gene-modified autologous stem cells (Gene-modified autologous stem cells)

Fanconi Anemia · Beta-Thalassemia

#Beta-Thalassemia#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 1%임상시험 50상태 ACTIVE
CGTBiologiciCell Gene TherapeuticsPhase 1

CD7 CAR T-cells (CD7 CAR T-cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Lymphoma · Crohn Disease

#CrohnDisease#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 49상태 ACTIVE
CGTBiologicSun Yat-sen UniversityPhase 2

Relmacabtagene Autoleucel (Autoleucel, Autoleucel (Relmacabtagene Autoleucel))

Large B Cell Diffuse Lymphoma; Mantle Cell Lymphoma (MCL) · Large B Cell Diffuse Lymphoma

#LargeBCellDiffuseLymphoma#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 38%임상시험 47상태 RECRUITING
CGTBiologicShenzhen Hornetcorn Bio-technol…Phase 1

Autologous NK cell therapy (Autologous NK cell therapy)

NK Cell Mediated Immunity; Endometriosis · NK Cell Mediated Immunity

#NKCellMediatedImmunity#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0.667%임상시험 47상태 ACTIVE

5 / 62 페이지

← 이전다음 →